Regeneron Pharmaceuticals, Inc.
NY-ESO-1 T CELL RECEPTORS AND METHODS OF USE THEREOF
Last updated:
Abstract:
The present invention provides isolated T cell receptors (TCRs) that specifically bind to an HLA-displayed New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1) peptides, as well as therapeutic and diagnostic methods of using those isolated TCRs.
Status:
Application
Type:
Utility
Filling date:
23 Oct 2019
Issue date:
30 Dec 2021